This article is part of the supplement: B cell targeted therapy: a new approach to the treatment of rheumatoid arthritis
Review
B cell non-Hodgkin's lymphoma: rituximab safety experience
Arthritis Research & Therapy 2005, 7(Suppl 3):S19-S25 doi:10.1186/ar1739
No comments have yet been made on this article.
